Board/Management Information • May 22, 2018
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 7895O
Tekcapital plc
22 May 2018
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.
22 May 2018
Tekcapital plc
("Tekcapital" or the "Company")
Salarius Ltd Appoints Directors
Tekcapital plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from university technology, announces that Salarius Ltd, the developer of Microsalt, a proprietary low-sodium salt product, has added Eduardo Souchon and Steve McCready to its board of directors. Salarius ltd is a 100% wholly owned Tekcapital portfolio company.
Mr. Souchon is a business, brand and marketing executive with two decades of experience in taking businesses focused on snacks (Pringles®), health products and office supplies to commercial success in the consumer packaged goods (CPG) industry and the retail industry. Eduardo has significant end-to-end experience in brand building, innovation, and strategy gained from Procter and Gamble and Office Depot.
Mr. McCready has 18 years of innovation-focused product development experience in multiple product categories, with particular expertise in process development, scaling, and commercialisation. Recently, Steve served as Director of Product Development at Albertson's Companies, Inc., a leading U.S. supermarket company with more than $60bn in sales and 2,300 locations. Previously, Steve held positions as a research scientist at White Wave and ConAgra Foods and was product development project leader at Nestlé Ice Cream Company.
Dr. Clifford Gross, director at Salarius Ltd., said: "We are very excited to add Eduardo and Steve to Salarius' Board of directors, and we look forward to creating market value from Salarius' patented technology. Together we plan to explore the possible development and launch of Neosnax™, a new, healthy choice snack food brand that has all of the flavor and roughly half the sodium of most currently available snack foods."
About Salarius, Ltd.
Salarius has developed a patented process for producing nano particle edible salt crystals. The use of its edible salt crystals for topical food applications can deliver all of the flavour customers expect with about half of the sodium versus traditional salt. The mission of Salarius is to commercialize low-sodium Microsalt to improve the nutritional content of food and the health of individuals worldwide. To learn more, please visit www.salarius.co.
For further information, please contact:
| Tekcapital Plc | Via Walbrook PR |
| Clifford M. Gross, Ph.D. | |
| Allenby Capital Limited (Nominated Adviser & Joint Broker) | +44 (0) 20 3328 5656 |
| Jeremy Porter / Alex Brearley | |
| Dowgate Capital Stockbrokers (Joint Broker) | +44 (0) 1293 517744 |
| David Poutney / James Serjeant | |
| Walbrook PR Ltd | +44 (0) 20 7933 8780 |
| Paul Cornelius / Helen Cresswell / Sam Allen | [email protected] |
Tekcapital plc - The World's Largest University Network for Open Innovation
Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com
LEI: 213800GOJTOV19FIFZ85
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BOABLGDUSXDBGIB
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.